Background illustration for clinical trials search

Gilead Clinical Trials

Find clinical trials for Gilead. Search for Gilead clinical trials in different cities and states across the United States.

Filter
Active & Responsive

Study of GS-0415 and How It Works in People With HIV

for
HIV -1 Infection
Location: Boston MA, The Bronx NY, Washington D.C. DC, Durham NC,
Sponsor: Gilead Sciences

Sex: All

Age: 18 - 65

Code: NCT07719491

Phase 1, Recruiting
Active & Responsive

A Study of GS-3242 in Combination With Lenacapavir Versus Biktarvy in Virologically Suppressed People With HIV-1

for
HIV-1-infection
Location: Flushing NY, Brooklyn NY, New York NY, Newark NJ,
Sponsor: Gilead Sciences

Sex: All

Age: 18+

Code: NCT07645287

Phase 2, Recruiting
Active & Responsive

Study of GS-4321 in Healthy Participants and Participants With Chronic Hepatitis Delta Virus

for
Chronic Hepatitis Delta
Location: New York NY, Baltimore MD, Louisville KY, La Jolla CA,
Sponsor: Gilead Sciences

Sex: All

Age: 18 - 69

Code: NCT07096193

Phase 1, Phase 2, Recruiting
Active & Responsive

Study of GS-4571 in Healthy Participants, Nondiabetic Obese Participants, and Nonobese Participants With Type 2 Diabetes Mellitus (T2DM)

for
Weight Management
Location: Miami FL, San Antonio TX, Salt Lake City UT
Sponsor: Gilead Sciences

Sex: All

Age: 18 - 65

Code: NCT06562907

Phase 1, Recruiting

Seladelpar in Subjects With Primary Biliary Cholangitis (PBC) and Compensated Cirrhosis

for
Primary Biliary Cholangitis
Location: Boston MA, Quebec, New York NY, Manhasset NY, Montreal,
Sponsor: Gilead Sciences

Sex: All

Age: 18+

Code: NCT06051617

Phase 3, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Study of GS-0201 Alone and in Combination in Participants With Advanced Solid Tumors

for
Advanced Solid Tumors
Location: Boston MA, New York NY, Houston TX, Irving TX,
Sponsor: Gilead Sciences

Sex: All

Age: 18+

Code: NCT06167317

Phase 1, Recruiting

Study of Sacituzumab Govitecan Versus Standard of Care in Participants With Previously Treated Extensive Stage Small Cell Lung Cancer

for
Extensive Stage Small Cell Lung Cancer (ES-SCLC)
Location: Rimouski, Montreal, Easton PA, Miami FL, Toronto,
Sponsor: Gilead Sciences

Sex: All

Age: 18+

Code: NCT06801834

Phase 3, Recruiting

Study of KITE-363 or KITE-753 in Participants With Relapsed and/or Refractory B-cell Lymphoma

for
Relapsed and/or Refractory B-cell Lymphoma
Location: New York NY, Hackensack NJ, Montreal, Norfolk VA,
Sponsor: Kite, A Gilead Company

Sex: All

Age: 18+

Code: NCT04989803

Phase 1, Phase 2, Recruiting

Study of GS-2121 Given Alone or in Combination in Adults With Advanced Solid Tumors

for
Advanced Solid Tumors
Location: Boston MA, Ottawa, Fairfax VA, Toronto, San Antonio TX,
Sponsor: Gilead Sciences

Sex: All

Age: 18+

Code: NCT06532565

Phase 1, Recruiting

Study of Sacituzumab Govitecan in Participants With Advanced or Metastatic Solid Tumor and Moderate Liver Impairment

for
Advanced or Metastatic Solid Tumor, Liver Failure
Location: Newark DE, Baltimore MD, Houston TX, San Antonio TX
Sponsor: Gilead Sciences

Sex: All

Age: 18+

Code: NCT04617522

Phase 1, Recruiting

A Study to Evaluate the Safety and Antitumor Activity of GS-1206 in Adults With Solid Tumors

for
Solid Tumor
Location: Grand Rapids MI, Texas City TX, San Antonio TX
Sponsor: Gilead Sciences

Sex: All

Age: 18+

Code: NCT07703878

Phase 1, Recruiting

Study of Lenacapavir, Teropavimab, and Zinlirvimab Versus Cabotegravir and Rilpivirine in Virologically Suppressed Adults With HIV-1 on Oral Daily Antiretroviral Therapy

for
HIV Infections
Location: Annandale VA, Fort Lauderdale FL, West Palm Beach FL,
Sponsor: Gilead Sciences

Sex: All

Age: 18+

Code: NCT07682961

Phase 3, Recruiting

Study of Denikitug (GS-1811) Given Alone or With Nivolumab or Chemotherapy in Adults With Metastatic Gastric, Gastroesophageal Junction (GEJ), and Esophageal Adenocarcinomas

for
HER2-negative, Gastroesophageal Junction,
Location: Boston MA, New York NY, Albany NY
Sponsor: Gilead Sciences

Sex: All

Age: 18+

Code: NCT07546812

Phase 2, Recruiting

Study of GS-2426 in Participants With Advanced Solid Tumors

for
Advanced Solid Tumors
Location: Boston MA, New York NY, East Brunswick NJ,
Sponsor: Gilead Sciences

Sex: All

Age: 18+

Code: NCT07601243

Phase 1, Recruiting

Study of Denikitug (GS-1811) Given Alone or With Nivolumab or With Chemotherapy in Adults With Advanced Colorectal Cancer

for
Advanced Microsatellite Stable Colorectal Cancer
Location: Boston MA, North Haven CT, Charlottesville VA,
Sponsor: Gilead Sciences

Sex: All

Age: 18+

Code: NCT07527858

Phase 2, Recruiting

Study Evaluating the Efficacy of KITE-753 Versus Axicabtagene Ciloleucel in Participants With Relapsed or Refractory Large B-Cell Lymphoma After First-Line Therapy

for
Relapsed or Refractory Large B-cell Lymphoma
Location: New Haven CT, Quebec, The Bronx NY, New York NY,
Sponsor: Kite, A Gilead Company

Sex: All

Age: 18+

Code: NCT07479797

Phase 3, Recruiting

Implementation Study of Lenacapavir Pre-exposure Prophylaxis for HIV Prevention

for
HIV Infections
Location: Boston MA, The Bronx NY, New York NY, Philadelphia PA,
Sponsor: Gilead Sciences

Sex: All

Age: 18+

Code: NCT07473778

Recruiting

Study of Lenacapavir, Teropavimab, and Zinlirvimab in Virologically Suppressed Adults With HIV-1 on Stable Oral Treatment Regimens

for
HIV-1-infection
Location: Annandale VA, Berkeley MI
Sponsor: Gilead Sciences

Sex: All

Age: 18+

Code: NCT07683000

Phase 3, Recruiting

Study of GS-5319 Given Alone or in Combination in Adults With Solid Tumors

for
Advanced Solid Tumor
Location: Boston MA, Fairfax VA, San Antonio TX
Sponsor: Gilead Sciences

Sex: All

Age: 18+

Code: NCT07128303

Phase 1, Recruiting

A Study Evaluating the Safety and Efficacy of KITE-363 in Relapsed/Refractory Autoimmune Neurologic Diseases

for
Chronic Inflammatory Demyelinating Polyneuropathy,
Location: New York NY, Montreal, Salt Lake City UT, Seattle WA,
Sponsor: Kite, A Gilead Company

Sex: All

Age: 18 - 70+

Code: NCT07304154

Phase 1, Recruiting